Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Goichot

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2025
Normal organ [<sup>68</sup>Ga]DOTATOC uptake during PRRT: challenging the assumption of stable background shaped by cold somatostatin analogues treatmentHind Ait Talhiq, Philippe Baltzinger, Juliette Frega, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2024
[<sup>68</sup>Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigationMiriam Pepponi, Valentina Berti, Elsa Fasciglione, et al.
Human Pathology|June 30, 2026
Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumorsAntonin Fattori, Xiaofan Lu, Philippe Baltzinger, et al.
Cancers|December 24, 2021
Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine ProceduresRoberto Luigi Cazzato, Fabrice Hubelé, Pierre De Marini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2019
Early <sup>18</sup>F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinomaBenjamin Leroy-Freschini, Vincent Amodru, Pietro Addeo, et al.
Metabolites|December 15, 2019
Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic MetastasesAlessio Imperiale, Gilles Poncet, Pietro Addeo, et al.
European Journal of Endocrinology|December 1, 2023
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN networkMarine Perrier, Mathias Brugel, Laura Gérard, et al.
European Journal of Endocrinology|February 9, 2013
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemiaValérie Bernard, Catherine Lombard-Bohas, Marie-Caroline Taquet, et al.
Cancers|July 2, 2021
Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine TumorsVéronique Debien, Guillaume Davidson, Philippe Baltzinger, et al.
Neurosurgical Review|January 16, 2024
Is the OCT a predictive tool to assess visual impairment in optic chiasm compressing syndrome in pituitary macroadenoma? A prospective longitudinal studyMaria Teresa Bozzi, Charles-Henry Mallereau, Julien Todeschi, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2025
Normal organ [<sup>68</sup>Ga]DOTATOC uptake during PRRT: challenging the assumption of stable background shaped by cold somatostatin analogues treatmentHind Ait Talhiq, Philippe Baltzinger, Juliette Frega, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2024
[<sup>68</sup>Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigationMiriam Pepponi, Valentina Berti, Elsa Fasciglione, et al.
Human Pathology|June 30, 2026
Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumorsAntonin Fattori, Xiaofan Lu, Philippe Baltzinger, et al.
Cancers|December 24, 2021
Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine ProceduresRoberto Luigi Cazzato, Fabrice Hubelé, Pierre De Marini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2019
Early <sup>18</sup>F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinomaBenjamin Leroy-Freschini, Vincent Amodru, Pietro Addeo, et al.
Metabolites|December 15, 2019
Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic MetastasesAlessio Imperiale, Gilles Poncet, Pietro Addeo, et al.
European Journal of Endocrinology|December 1, 2023
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN networkMarine Perrier, Mathias Brugel, Laura Gérard, et al.
European Journal of Endocrinology|February 9, 2013
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemiaValérie Bernard, Catherine Lombard-Bohas, Marie-Caroline Taquet, et al.
Cancers|July 2, 2021
Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine TumorsVéronique Debien, Guillaume Davidson, Philippe Baltzinger, et al.
Neurosurgical Review|January 16, 2024
Is the OCT a predictive tool to assess visual impairment in optic chiasm compressing syndrome in pituitary macroadenoma? A prospective longitudinal studyMaria Teresa Bozzi, Charles-Henry Mallereau, Julien Todeschi, et al.
Pageof 14